Figure 2.
Kaplan−Meier curves for the primary cardiovascular disease (CVD) outcome plus all-cause mortality in Systolic Blood Pressure Intervention Trial (SPRINT) for African American participants by treatment group and APOL1 risk genotype.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.